Assessment of PRRSV and PCV2 seroprevalence and antigen prevalence in minipigs at laboratory-animal production facilities
Keywords:
Experimental animal; Production facilities; Minipigs; Porcine circovirus type 2; Porcine reproductive and respiratory syndrome virusAbstract
Objective: Pigs are used in various biomedical research fields because of their anatomical and physiological similarities to humans. While farm pigs are raised outdoors for several months, minipigs are typically raised in indoor barrier facilities for several years. Although numerous studies have investigated the prevalence of major pathogens, including porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus type 2 (PCV2), in farm pigs, similar studies targeting minipigs are lacking. Materials and Methods: We imported 57 minipigs to our institution from three experimental animal production facilities and immediately assessed the serological and antigenic prevalence of PRRSV and PCV2. Results: PRRSV and PCV2 had seroprevalences of 80.7% and 94.7%, respectively, with 0% antigen positivity rates for PRRSV types 1 and 2 and high-pathogenic PRRSV and PCV2. Two factors could account for the high seroprevalence rates: the majority of individuals may have been vaccinated despite official claims from the origin facilities or exposed to PRRSV and PCV2. Preventing microbial infections is crucial for obtaining accurate and reproducible results. Conclusion: As the first investigation of microbial prevalence in minipigs, our findings indicate that minipigs raised in barrier facilities are not necessarily free from vaccines or infections. These results will significantly enhance the credibility of future biomedical research.
J. Adv. Vet. Anim. Res., 11(4): 1017–1022, December 2024
Downloads
20
24
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Yoon Beom Lee, Ji Woon Kim, Woori Jo, Tae Ku Kang, MinKyoung Sung, KilSoo Kim, Na Hye Park, Gwang-Hoon Lee

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).